EUVIMED · CrossrefJournal
Sarcoidosis vasculitis and diffuse lung diseases
ISSN 1124-0490
Frequent topics
sarcoidosisinterstitial lung diseaseidiopathic pulmonary fibrosispulmonary sarcoidosiscorticosteroid therapylung functioncardiac sarcoidosisdiffusing capacity for carbon monoxide6-minute walk testgranulomatous diseasepulmonary fibrosisimmunosuppressive therapy
Latest articles
Effect of home-based pulmonary rehabilitation in patients with interstitial lung disease in a tertiary care centre - A randomized controlled trial.
Effects of yoga-based and conventional physiotherapy programs on functional, respiratory, and psychosocial outcomes in stage II sarcoidosis: A randomized controlled trial.
Derivation of a peripheral blood-based transcriptomic risk score for extrapulmonary sarcoidosis.
Folate metabolism-related gene signature reveals prognostic and immunological characteristics in idiopathic pulmonary fibrosis.
Sarcoidosis in hospitalised patients in Western Australia: A long-term study on prevalence, comorbidity and mortality.
Postoperative acute exacerbations in patients with idiopathic pulmonary fibrosis undergoing lung cancer surgery.
Risk and characteristics of interstitial lung disease in patients with inflammatory bowel disease: A retrospective cohort study.
The prognostic value of the prognostic nutritional index in patients with sarcoidosis.
Reflections of upper extremity performance in idiopathic pulmonary fibrosis on exercise capacity, clinical status, and quality of life.
Trajectories of progressive pulmonary fibrosis and outcomes in connective tissue disease associated interstitial lung disease (CTD-ILD).
Peripheral immune checkpoint gene expression as diagnostic biomarkers in idiopathic pulmonary fibrosis.
Efficacy and safety of extended-release oral opioid for cough in idiopathic pulmonary fibrosis: A systematic review and meta-analysis of randomized controlled trials.
The onset of sarcoidosis in relation to tattoos: Focus on the treatment landscape. A critical literature review and case report.
Fibroblast proliferative capacity predicts prognosis in idiopathic pulmonary fibrosis and identifies PITX1 as a growth-associated gene.
Bilateral corneal keratolysis (corneal melt) in sarcoidosis.
Bone involvement in sarcoidosis: Insights from a multicentre Italian cohort.
Unveiling novel susceptibility genes for sarcoidosis by a cross-tissue transcriptome-wide association study.
Cutoffs for serum mold-specific IgG levels for hypersensitivity pneumonitis: a diagnostic test accuracy study of 219 subjects.
Transcriptomic profiling of collagen gene expression in lung fibroblasts from patients with idiopathic pulmonary fibrosis.
Dual pathology, dual burden: Functional impact of emphysema and fibrosis in Hypersensitivity Pneumonitis.
Supervised Home-Based Telerehabilitation for Idiopathic Pulmonary Fibrosis: A Pragmatic Service Evaluation in Routine Care with Detraining Follow-up.
Outcomes of Lung Transplantation for Pulmonary Sarcoidosis Across Multiple Eras: A 25-Year Experience from a US Center.
Quality of AI chatbot-generated information on hypersensitivity pneumonitis for clinical and patient use.
In-hospital Mortality Associated with Granulomatosis with Polyangiitis and Microscopic Polyangiitis Complicated with Respiratory Failure.
Advances in management of sarcoidosis-associated fatigue: A narrative review.
The Diagnostic Course of Sarcoidosis: A Population-Based Study Highlighting Risk Factors for a Delay in Diagnosis.
Composite Inflammatory Indices for the Differentiation of Tuberculosis, Sarcoidosis, and Reactive Lymphadenopathy in Patients Undergoing EBUS-TBNA.
Clinical features, diagnosis, and outcome of anaplastic lymphoma kinase tyrosine kinase inhibitors associated interstitial lung disease.
A case of a rapidly progressing, recurrent orbital mass.
Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD).
EUVIMED